Juul K V
Laegemiddelstyrelsen, Brønshøj.
Ugeskr Laeger. 1998 May 25;160(22):3207-11.
The aim of this study was to explore the utilization of calcium, vitamin D and bishosphonates used in treatment of osteoporosis. The data derive from the Register of Drug Statistics at the Danish Medicines Agency. The analysis encompassed 112,300 prescriptions presented by 25,692 patients during a period from 1 January 1994 to 30 June 1996. The consumption of calcium decreased, while the consumption of bisphosphonates increased 971% during the period. The one-year prevalence of use of calcium, vitamin D and bishosphonates was 3.5 per 1000 in 1995 with a female to male ratio of 6.8:1. Use was most common in the age group 75-79 years. Twenty-seven percent of the patients had used corticosteroids previously to being treated for osteoporosis; 1.4% of the patients had used cumulative corticosteroid doses greater than 10 g. These heavy users were treated with five times larger doses against osteoporosis than patients not treated with corticosteroids.
本研究旨在探讨用于治疗骨质疏松症的钙、维生素D和双膦酸盐的使用情况。数据来源于丹麦药品管理局的药品统计登记册。分析涵盖了1994年1月1日至1996年6月30日期间25692名患者开具的112300份处方。在此期间,钙的使用量减少,而双膦酸盐的使用量增加了971%。1995年,钙、维生素D和双膦酸盐的一年使用患病率为每1000人中有3.5人,女性与男性的比例为6.8:1。使用情况在75 - 79岁年龄组中最为常见。27%的患者在接受骨质疏松症治疗之前曾使用过皮质类固醇;1.4%的患者累积使用皮质类固醇剂量超过10克。这些大量使用者接受治疗骨质疏松症的剂量是未接受皮质类固醇治疗患者的五倍。